APPLICATION
ANDA202624
TYPE
ANDA
ORIGINAL APPROVAL
2013-09-18
LATEST ACTION
2020-06-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
GANCICLOVIR SODIUMDiscontinued
GANCICLOVIR SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-06-08Labeling · Supplement 3 · standardAP
2020-06-08Labeling · Supplement 2 · standardAP
2013-09-18UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.